Investing in biotechnology

Galenicum has invested in one major biotechnology project: Bionure.

Bionure

Based in Barcelona’s Parc Científic science park; new offices will soon be opened in San Francisco, California.

  • Developing an NCE for multiple sclerosis.
  • Potential applications in the treatment of neuro-degenerative diseases such as Alzheimer's and Parkinson's.